
    
      This protocol will test the hypothesis that an intracoronary infusion of autologous,
      unfractionated, bone marrow mononuclear cells will attenuate infarct size and improve
      left-ventricular function in 60 patients following an acute anterior myocardial infarction
      who have undergone successful revascularization with PTCA/stenting.
    
  